1. IAEA. Cytogenetic Dosimetry: Applications in Preparedness for and Response to Radiation Emergences, International Atomic Energy Agency, 2011.
2. Nugis, V.Yu., Sevan’kaev, A.V., Khvostunov, I.K., et al., The results of 25 year-cytogenetic investigation of survivors exposed to different doses of irradiation in the Chernobyl accident, Radiats. Biol. Radioecol., 2011, vol. 51, no. 1, pp. 81–90.
3. Khvostunov, I.K., Snigiryova, G.P., Moiseenko, V.V., and Lloyd, D.C., A follow-up cytogenetic study of workers highly exposed inside the Chernobyl sarcophagus, Radiat. Prot. Dosim., 2015, vol. 167, no. 4, pp. 405–418. http://www.memoid.ru/node/Perspektivy_atomnoj_ ehnergetiki_sovremennoj_Rossii-cite_ref-.D0.B0.D1. 82.D0.BE.D0.BC_12-7.https://doi.org/10.1093/rpd/ncu351
4. Biologicheskaya indikatsiya radiatsionnogo vozdeistviya na organizm cheloveka s ispol’zovaniem tsitogeneticheskikh metodov: med. tekhnologiya № FS-2007/015-U (Biological Indication of Radiation Effects on the Human Body Using Cytogenetic Methods: Medical Technology no. FS-2007/015-U), Moscow: Ross. Nauchn. Tsentr Rentgenoradiol., Inst. Obshch. Genet. im. N.I. Vavilova, 2007.
5. Nowell, P.C., Phytohemagglutinin—an initiator of mitosis in cultures of normal human leukocytes, Cancer Res., 1960, vol. 20, no. 4, pp. 462–466.